Shiffman ML - Search Results

1

Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease.

Muir AJ, Levy C, Janssen HLA, Montano-Loza AJ, Shiffman ML, Caldwell S, Luketic V, Ding D, Jia C, McColgan BJ, McHutchison JG, Mani Subramanian G, Myers RP, Manns M, Chapman R, Afdhal NH, Goodman Z, Eksteen B, Bowlus CL; GS-US-321-0102 Investigators. Muir AJ, et al. Among authors: shiffman ml. Hepatology. 2019 Feb;69(2):684-698. doi: 10.1002/hep.30237. Epub 2019 Jan 11. Hepatology. 2019. PMID: 30153359 Clinical Trial.

2

Primary hepatocellular carcinoma after orthotopic liver transplantation for chronic hepatitis B infection.

Luketic VA, Shiffman ML, McCall JB, Posner MP, Mills AS, Carithers RL Jr. Luketic VA, et al. Among authors: shiffman ml. Ann Intern Med. 1991 Feb 1;114(3):212-3. doi: 10.7326/0003-4819-114-3-212. Ann Intern Med. 1991. PMID: 1845838 No abstract available.

3

Liver transplantation in Virginia.

Shiffman ML, Posner MP, Luketic V, Mills AS, Berman W, Whitman A, Lee HM, Carithers RL Jr. Shiffman ML, et al. Va Med Q. 1990 Autumn;117(8):354-60. Va Med Q. 1990. PMID: 2260387

4

Bleeding gastroesophageal varices.

Sanyal AJ, Purdum PP 3rd, Luketic VA, Shiffman ML. Sanyal AJ, et al. Among authors: shiffman ml. Semin Liver Dis. 1993 Nov;13(4):328-42. doi: 10.1055/s-2007-1007361. Semin Liver Dis. 1993. PMID: 7905668 Review. No abstract available.

5

Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study.

Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP 3rd, Luketic VA, Cheatham AK. Sanyal AJ, et al. Among authors: shiffman ml. Hepatology. 1994 Jul;20(1 Pt 1):46-55. doi: 10.1016/0270-9139(94)90133-3. Hepatology. 1994. PMID: 8020904 Clinical Trial.

6

Biochemical and histologic evaluation of recurrent hepatitis C following orthotopic liver transplantation.

Shiffman ML, Contos MJ, Luketic VA, Sanyal AJ, Purdum PP 3rd, Mills AS, Fisher RA, Posner MP. Shiffman ML, et al. Transplantation. 1994 Feb 27;57(4):526-32. Transplantation. 1994. PMID: 8116036

7

Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis.

Shiffman ML, Luketic VA, Sanyal AJ, Duckworth PF, Purdum PP 3rd, Contos MJ, Mills AS, Edinboro LE, Poklis A. Shiffman ML, et al. Hepatology. 1994 Apr;19(4):933-40. Hepatology. 1994. PMID: 8138268

8

Hepatic lidocaine metabolism is useful in the selection of patients in need of liver transplantation.

Luketic VA, Shiffman ML, Fisher RA, Sanyal AJ, Purdum PP 3rd, Posner MP. Luketic VA, et al. Among authors: shiffman ml. Transplant Proc. 1993 Feb;25(1 Pt 2):1072-4. Transplant Proc. 1993. PMID: 8442046 No abstract available.

9

Results with percutaneous transjugular intrahepatic portosystemic stent-shunts for control of variceal hemorrhage in patients awaiting liver transplantation.

Freedman AM, Sanyal AJ, Tisnado J, Shiffman ML, Luketic VA, Fisher RA, Posner MP. Freedman AM, et al. Among authors: shiffman ml. Transplant Proc. 1993 Feb;25(1 Pt 2):1087-9. Transplant Proc. 1993. PMID: 8442051 No abstract available.

10

Hepatic lidocaine metabolism and complications of cirrhosis. Implications for assessing patient priority for hepatic transplantation.

Shiffman ML, Fisher RA, Sanyal AJ, Edinboro LE, Luketic VA, Purdum PP 3rd, Raymond P, Posner MP. Shiffman ML, et al. Transplantation. 1993 Apr;55(4):830-5. doi: 10.1097/00007890-199304000-00028. Transplantation. 1993. PMID: 8475560

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

359 results

Search Page